Scott Loren Pomeroy, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medulloblastoma | 65 | 2024 | 678 | 7.750 |
Why?
|
| Cerebellar Neoplasms | 43 | 2024 | 587 | 5.690 |
Why?
|
| Neurology | 9 | 2023 | 769 | 1.830 |
Why?
|
| Brain Neoplasms | 34 | 2020 | 8895 | 1.050 |
Why?
|
| Craniopharyngioma | 9 | 2012 | 278 | 0.980 |
Why?
|
| Hedgehog Proteins | 16 | 2024 | 769 | 0.820 |
Why?
|
| Pediatrics | 6 | 2016 | 3572 | 0.630 |
Why?
|
| Ependymoma | 5 | 2015 | 320 | 0.620 |
Why?
|
| Astrocytoma | 11 | 2013 | 777 | 0.610 |
Why?
|
| Nervous System Diseases | 4 | 2023 | 1625 | 0.600 |
Why?
|
| Neuroectodermal Tumors, Primitive | 5 | 2014 | 138 | 0.540 |
Why?
|
| Gene Expression Profiling | 23 | 2024 | 9355 | 0.520 |
Why?
|
| Cell Tracking | 1 | 2016 | 140 | 0.510 |
Why?
|
| Child | 75 | 2023 | 78996 | 0.500 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2014 | 349 | 0.500 |
Why?
|
| Central Nervous System Neoplasms | 3 | 2015 | 906 | 0.460 |
Why?
|
| Receptors, Nerve Growth Factor | 7 | 2002 | 197 | 0.450 |
Why?
|
| Gene Expression Regulation, Neoplastic | 20 | 2019 | 8420 | 0.450 |
Why?
|
| Disabled Children | 1 | 2016 | 249 | 0.440 |
Why?
|
| Bullying | 1 | 2016 | 212 | 0.430 |
Why?
|
| Genomics | 12 | 2019 | 5728 | 0.430 |
Why?
|
| Transcription Factors | 13 | 2017 | 12060 | 0.410 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2011 | 3788 | 0.400 |
Why?
|
| Crime Victims | 1 | 2016 | 324 | 0.400 |
Why?
|
| DNA-Binding Proteins | 13 | 2016 | 9554 | 0.390 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2011 | 62 | 0.390 |
Why?
|
| Epigenesis, Genetic | 8 | 2020 | 3705 | 0.390 |
Why?
|
| Cell Lineage | 5 | 2019 | 2511 | 0.380 |
Why?
|
| MicroRNAs | 8 | 2019 | 3765 | 0.370 |
Why?
|
| Internship and Residency | 2 | 2023 | 5810 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-myc | 7 | 2021 | 989 | 0.350 |
Why?
|
| Signal Transduction | 22 | 2019 | 23235 | 0.350 |
Why?
|
| Chromosomal Proteins, Non-Histone | 7 | 2013 | 723 | 0.350 |
Why?
|
| Receptors, GABA-A | 1 | 2014 | 624 | 0.350 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2010 | 71 | 0.340 |
Why?
|
| Apoptosis | 13 | 2017 | 9436 | 0.340 |
Why?
|
| Intracellular Fluid | 1 | 2009 | 201 | 0.340 |
Why?
|
| Wnt Proteins | 10 | 2017 | 720 | 0.330 |
Why?
|
| Mutation | 19 | 2024 | 29712 | 0.330 |
Why?
|
| Pinealoma | 2 | 2019 | 51 | 0.330 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 493 | 0.310 |
Why?
|
| Child, Preschool | 46 | 2021 | 41656 | 0.310 |
Why?
|
| Tumor Suppressor Protein p53 | 9 | 2017 | 2895 | 0.300 |
Why?
|
| Humans | 145 | 2024 | 752810 | 0.300 |
Why?
|
| Rhabdoid Tumor | 8 | 2016 | 205 | 0.300 |
Why?
|
| Complementary Therapies | 1 | 2011 | 485 | 0.300 |
Why?
|
| Nerve Growth Factors | 5 | 1999 | 561 | 0.290 |
Why?
|
| Neuroglia | 4 | 2019 | 940 | 0.280 |
Why?
|
| Pituitary Neoplasms | 6 | 2010 | 1308 | 0.280 |
Why?
|
| Membrane Proteins | 6 | 2014 | 7814 | 0.280 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2009 | 196 | 0.280 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 599 | 0.280 |
Why?
|
| Pineal Gland | 3 | 2019 | 157 | 0.280 |
Why?
|
| Cerebellum | 8 | 2024 | 1495 | 0.270 |
Why?
|
| Neurosciences | 1 | 2011 | 355 | 0.270 |
Why?
|
| Radiotherapy | 5 | 2014 | 1507 | 0.270 |
Why?
|
| Hospitals, Pediatric | 1 | 2016 | 1830 | 0.270 |
Why?
|
| Behavior Therapy | 1 | 2011 | 854 | 0.260 |
Why?
|
| Genes, p53 | 4 | 2013 | 710 | 0.260 |
Why?
|
| Developmental Disabilities | 3 | 2019 | 1509 | 0.260 |
Why?
|
| Plant Poisoning | 1 | 2005 | 13 | 0.260 |
Why?
|
| Child Behavior | 1 | 2011 | 842 | 0.260 |
Why?
|
| Receptors, Notch | 1 | 2010 | 738 | 0.260 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2017 | 2796 | 0.260 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 6 | 1999 | 1618 | 0.250 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2005 | 66 | 0.250 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2019 | 2821 | 0.250 |
Why?
|
| Down-Regulation | 3 | 2012 | 2910 | 0.240 |
Why?
|
| Prognosis | 22 | 2021 | 29369 | 0.240 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 491 | 0.240 |
Why?
|
| Wallerian Degeneration | 3 | 2008 | 68 | 0.240 |
Why?
|
| Moyamoya Disease | 1 | 2007 | 239 | 0.230 |
Why?
|
| Ganglioglioma | 1 | 2003 | 37 | 0.230 |
Why?
|
| Melatonin | 1 | 2009 | 667 | 0.230 |
Why?
|
| Hypothalamic Diseases | 1 | 2005 | 134 | 0.230 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 2 | 2017 | 168 | 0.220 |
Why?
|
| Brain Abscess | 1 | 2004 | 118 | 0.220 |
Why?
|
| Education, Medical, Graduate | 2 | 2016 | 2321 | 0.220 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2017 | 1873 | 0.220 |
Why?
|
| Myoclonus | 1 | 2003 | 106 | 0.220 |
Why?
|
| Adolescent | 43 | 2021 | 86822 | 0.210 |
Why?
|
| Age Factors | 5 | 2019 | 18302 | 0.210 |
Why?
|
| Receptor, trkC | 6 | 2005 | 63 | 0.210 |
Why?
|
| Athletic Injuries | 1 | 2012 | 1179 | 0.210 |
Why?
|
| Histone Demethylases | 2 | 2024 | 323 | 0.210 |
Why?
|
| Cell Proliferation | 10 | 2021 | 10358 | 0.210 |
Why?
|
| Embryo, Mammalian | 3 | 2024 | 1662 | 0.210 |
Why?
|
| Cell Line, Tumor | 19 | 2019 | 16739 | 0.200 |
Why?
|
| Growth Substances | 2 | 2003 | 764 | 0.200 |
Why?
|
| Antineoplastic Agents | 7 | 2021 | 13558 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2012 | 3589 | 0.190 |
Why?
|
| Brain Concussion | 1 | 2012 | 1355 | 0.190 |
Why?
|
| Polyomavirus | 1 | 2002 | 235 | 0.190 |
Why?
|
| Postoperative Complications | 8 | 2009 | 15438 | 0.190 |
Why?
|
| Radiation Injuries | 3 | 2007 | 1180 | 0.190 |
Why?
|
| Survivors | 2 | 2012 | 2330 | 0.190 |
Why?
|
| Infant | 26 | 2020 | 35673 | 0.190 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2022 | 114 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2018 | 17650 | 0.190 |
Why?
|
| Genome, Human | 4 | 2017 | 4401 | 0.180 |
Why?
|
| Akinetic Mutism | 1 | 2000 | 11 | 0.180 |
Why?
|
| Polyomavirus Infections | 1 | 2002 | 196 | 0.180 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 25 | 0.170 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2018 | 494 | 0.170 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 438 | 0.170 |
Why?
|
| Medical Oncology | 1 | 2011 | 2284 | 0.170 |
Why?
|
| Chromosome Aberrations | 4 | 2012 | 1767 | 0.170 |
Why?
|
| Genetic Testing | 3 | 2023 | 3504 | 0.170 |
Why?
|
| Cannabis | 1 | 2005 | 436 | 0.160 |
Why?
|
| Embryonic Development | 1 | 2024 | 711 | 0.160 |
Why?
|
| Single-Cell Analysis | 3 | 2019 | 2318 | 0.160 |
Why?
|
| Mice | 40 | 2024 | 80551 | 0.160 |
Why?
|
| Seizures | 3 | 2021 | 2910 | 0.160 |
Why?
|
| Memory Disorders | 2 | 2006 | 1185 | 0.160 |
Why?
|
| Animals | 49 | 2024 | 166825 | 0.160 |
Why?
|
| Germinoma | 1 | 1999 | 132 | 0.160 |
Why?
|
| Glutathione | 1 | 2021 | 566 | 0.160 |
Why?
|
| DNA Methylation | 7 | 2018 | 4298 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2019 | 9207 | 0.150 |
Why?
|
| Syncope | 1 | 2021 | 424 | 0.150 |
Why?
|
| Carboplatin | 1 | 2021 | 790 | 0.150 |
Why?
|
| Nervous System Malformations | 1 | 2000 | 245 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2017 | 1125 | 0.150 |
Why?
|
| Tubulin | 2 | 2013 | 699 | 0.150 |
Why?
|
| Schwann Cells | 3 | 2008 | 197 | 0.150 |
Why?
|
| Neurotrophin 3 | 4 | 2005 | 61 | 0.140 |
Why?
|
| Gene Dosage | 4 | 2011 | 1222 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 6 | 2017 | 5780 | 0.140 |
Why?
|
| Germ-Line Mutation | 2 | 2018 | 1821 | 0.140 |
Why?
|
| Otx Transcription Factors | 1 | 2017 | 42 | 0.140 |
Why?
|
| Academies and Institutes | 1 | 2019 | 316 | 0.140 |
Why?
|
| Proto-Oncogenes | 1 | 1997 | 319 | 0.140 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 1741 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2023 | 1745 | 0.140 |
Why?
|
| Male | 61 | 2021 | 355160 | 0.140 |
Why?
|
| Neoplasm, Residual | 1 | 2021 | 994 | 0.140 |
Why?
|
| Genomic Instability | 2 | 2012 | 694 | 0.140 |
Why?
|
| Standard of Care | 1 | 2020 | 548 | 0.140 |
Why?
|
| Spasms, Infantile | 1 | 2020 | 318 | 0.130 |
Why?
|
| Parasympathetic Nervous System | 1 | 1996 | 140 | 0.130 |
Why?
|
| Sleep | 2 | 2009 | 4712 | 0.130 |
Why?
|
| Choroid Plexus Neoplasms | 2 | 2006 | 38 | 0.130 |
Why?
|
| DNA Mutational Analysis | 4 | 2018 | 4112 | 0.130 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2016 | 133 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 7407 | 0.130 |
Why?
|
| Clinical Competence | 1 | 2011 | 4713 | 0.130 |
Why?
|
| DNA, Viral | 1 | 2002 | 2176 | 0.130 |
Why?
|
| Central Nervous System | 2 | 2000 | 1331 | 0.130 |
Why?
|
| Sciatic Nerve | 2 | 2002 | 608 | 0.130 |
Why?
|
| Neoplasms | 6 | 2023 | 21810 | 0.120 |
Why?
|
| Diagnosis, Differential | 8 | 2021 | 12918 | 0.120 |
Why?
|
| Drug Design | 2 | 2012 | 1057 | 0.120 |
Why?
|
| Neurons | 8 | 2019 | 9352 | 0.120 |
Why?
|
| Female | 56 | 2021 | 386339 | 0.120 |
Why?
|
| RNA-Binding Proteins | 2 | 2014 | 1893 | 0.120 |
Why?
|
| Nuclear Proteins | 8 | 2018 | 5786 | 0.110 |
Why?
|
| Chromatin | 4 | 2024 | 2916 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 1341 | 0.110 |
Why?
|
| Receptor, trkB | 2 | 2013 | 125 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2018 | 1953 | 0.110 |
Why?
|
| Survival Analysis | 8 | 2019 | 10187 | 0.110 |
Why?
|
| Headache | 1 | 2001 | 1235 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2017 | 1338 | 0.110 |
Why?
|
| Phenotype | 9 | 2023 | 16440 | 0.110 |
Why?
|
| Hepatoblastoma | 1 | 2013 | 88 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 5 | 2012 | 4411 | 0.110 |
Why?
|
| International Agencies | 1 | 2013 | 244 | 0.110 |
Why?
|
| Antigens, Neoplasm | 3 | 2010 | 1989 | 0.110 |
Why?
|
| Mobius Syndrome | 1 | 2013 | 41 | 0.110 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2013 | 101 | 0.110 |
Why?
|
| Glioma | 5 | 2013 | 3394 | 0.110 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2014 | 194 | 0.100 |
Why?
|
| Olfactory Bulb | 2 | 1992 | 198 | 0.100 |
Why?
|
| Cell Movement | 2 | 2017 | 5174 | 0.100 |
Why?
|
| Neuropsychological Tests | 4 | 2006 | 6968 | 0.100 |
Why?
|
| Genomic Structural Variation | 1 | 2012 | 64 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 2900 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 629 | 0.100 |
Why?
|
| Adult | 32 | 2023 | 217168 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 241 | 0.100 |
Why?
|
| Teratoma | 2 | 2005 | 401 | 0.100 |
Why?
|
| Kallmann Syndrome | 1 | 2013 | 139 | 0.100 |
Why?
|
| RNA, Neoplasm | 2 | 2010 | 750 | 0.100 |
Why?
|
| DNA Copy Number Variations | 4 | 2019 | 2007 | 0.100 |
Why?
|
| Telomerase | 2 | 2014 | 740 | 0.100 | |